1. Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable. Dai C, Walker JT, Shostak A, Padgett A, Spears E, Wisniewski S, Poffenberger G, Aramandla R, Dean ED, Prasad N, Levy SE, Greiner DL, Shultz LD, Bottino R, Powers AC (2020) JCI Insight 5(1)
    › Primary publication · 31941840 (PubMed) · PMC7030815 (PubMed Central)
  2. Repeatability and Reproducibility of Pancreas Volume Measurements Using MRI. Williams JM, Hilmes MA, Archer B, Dulaney A, Du L, Kang H, Russell WE, Powers AC, Moore DJ, Virostko J (2020) Sci Rep 10(1): 4767
    › Primary publication · 32179809 (PubMed) · PMC7076034 (PubMed Central)
  3. Lipid Droplet Accumulation in Human Pancreatic Islets Is Dependent On Both Donor Age and Health. Tong X, Dai C, Walker JT, Nair GG, Kennedy A, Carr RM, Hebrok M, Powers AC, Stein R (2020) Diabetes 69(3): 342-354
    › Primary publication · 31836690 (PubMed) · PMC7034188 (PubMed Central)
  4. Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset. Virostko J, Williams J, Hilmes M, Bowman C, Wright JJ, Du L, Kang H, Russell WE, Powers AC, Moore DJ (2019) Diabetes Care 42(2): 248-257
    › Primary publication · 30552135 (PubMed) · PMC6341292 (PubMed Central)
  5. Imaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue. Prentice BM, Hart NJ, Phillips N, Haliyur R, Judd A, Armandala R, Spraggins JM, Lowe CL, Boyd KL, Stein RW, Wright CV, Norris JL, Powers AC, Brissova M, Caprioli RM (2019) Diabetologia 62(6): 1036-1047
    › Primary publication · 30955045 (PubMed) · PMC6553460 (PubMed Central)
  6. Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks. Haliyur R, Tong X, Sanyoura M, Shrestha S, Lindner J, Saunders DC, Aramandla R, Poffenberger G, Redick SD, Bottino R, Prasad N, Levy SE, Blind RD, Harlan DM, Philipson LH, Stein RW, Brissova M, Powers AC (2019) J Clin Invest 129(1): 246-251
    › Primary publication · 30507613 (PubMed) · PMC6307934 (PubMed Central)
  7. Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis. Saunders DC, Brissova M, Phillips N, Shrestha S, Walker JT, Aramandla R, Poffenberger G, Flaherty DK, Weller KP, Pelletier J, Cooper T, Goff MT, Virostko J, Shostak A, Dean ED, Greiner DL, Shultz LD, Prasad N, Levy SE, Carnahan RH, Dai C, Sévigny J, Powers AC (2019) Cell Metab 29(3): 745-754.e4
    › Primary publication · 30449685 (PubMed) · PMC6402969 (PubMed Central)
  8. α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes. Brissova M, Haliyur R, Saunders D, Shrestha S, Dai C, Blodgett DM, Bottino R, Campbell-Thompson M, Aramandla R, Poffenberger G, Lindner J, Pan FC, von Herrath MG, Greiner DL, Shultz LD, Sanyoura M, Philipson LH, Atkinson M, Harlan DM, Levy SE, Prasad N, Stein R, Powers AC (2018) Cell Rep 22(10): 2667-2676
    › Primary publication · 29514095 (PubMed) · PMC6368357 (PubMed Central)
  9. Cystic fibrosis-related diabetes is caused by islet loss and inflammation. Hart NJ, Aramandla R, Poffenberger G, Fayolle C, Thames AH, Bautista A, Spigelman AF, Babon JAB, DeNicola ME, Dadi PK, Bush WS, Balamurugan AN, Brissova M, Dai C, Prasad N, Bottino R, Jacobson DA, Drumm ML, Kent SC, MacDonald PE, Powers AC (2018) JCI Insight 3(8)
    › Primary publication · 29669939 (PubMed) · PMC5931120 (PubMed Central)
  10. Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Bonifacio E, Mathieu C, Nepom GT, Ziegler AG, Anhalt H, Haller MJ, Harrison LC, Hebrok M, Kushner JA, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson MA (2017) Diabetologia 60(1): 35-38
    › Primary publication · 27785529 (PubMed) · PMC5516264 (PubMed Central)